2. Surget S, Khoury MP, Bourdon JC. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther 2013;7:57–68.
6. Zhou L, Sun K, Zhao Y, Zhang S, Wang X, Li Y,
et al. Linc-YY1 promotes myogenic differentiation and muscle regeneration through an interaction with the transcription factor YY1. Nat Commun 2015;6:10026.
7. Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA-lncRNA interactions. Methods Mol Biol 2016;1402:271–286.
9. Ma L, Cao J, Liu L, Du Q, Li Z, Zou D,
et al. LncBook: a curated knowledgebase of human long non-coding RNAs. Nucleic Acids Res 2019;47:D128–D134.
11. Li Y, Zhao L, Zhao P, Liu Z. Long non-coding RNA LINC00641 suppresses non-small-cell lung cancer by sponging miR-424-5p to upregulate PLSCR4. Cancer Biomark 2019;26:79–91.
12. Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T,
et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol 2014;35:5441–5447.
15. Wang H, Chen W, Yang P, Zhou J, Wang K, Tao Q. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis. Cancer Biol Ther 2019;20:461–473.
16. Bian Z, Zhang J, Li M, Feng Y, Yao S, Song M,
et al. Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p. Oncogenesis 2017;6:395.
17. Zheng JJ, Du XJ, Wang HP, Zhou LY, Wang YJ, Zhang L,
et al. Long non-coding RNA 00152 promotes cell proliferation in cervical cancer via regulating miR-216b-5p/HOXA1 axis. Eur Rev Med Pharmacol Sci 2019;23:3654–3663.
18. Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li C,
et al. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1α via miR-138. Open Biol 2017;7:160247.
19. Sun K, Hu P, Xu F. LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1. Biomed Pharmacother 2018;97:1296–1302.
20. Zheng L, Hu N, Zhou X. TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis. Pathol Res Pract 2019;215:373–380.
21. Ma P, Wang H, Sun J, Liu H, Zheng C, Zhou X,
et al. LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis. Cell Cycle 2018;17:974–984.
22. Zhang X, Tao W. Long noncoding RNA LINC00152 facilitates the leukemogenesis of acute myeloid leukemia by promoting CDK9 through miR-193a. DNA Cell Biol 2019;38:236–242.
23. Cai J, Zhang J, Wu P, Yang W, Ye Q, Chen Q,
et al. Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway. J Neurooncol 2018;140:225–236.
24. Liu D, Gao M, Wu K, Zhu D, Yang Y, Zhao S. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis. Biomed Pharmacother 2019;112:108654.
25. Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G,
et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget 2015;6:42813–42824.
27. Chen WM, Huang MD, Sun DP, Kong R, Xu TP, Xia R,
et al. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer. Oncotarget 2016;7:9773–9787.
28. Xian-Li T, Hong L, Hong Z, Yuan L, Jun-Yong D, Peng X,
et al. Higher expression of Linc00152 promotes bladder cancer proliferation and metastasis by activating the Wnt/β-catenin signaling pathway. Med Sci Monit 2019;25:3221–3230.
30. Zhang Y, Xiang C, Wang Y, Duan Y, Liu C, Jin Y,
et al. lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway. Biomed Pharmacother 2017;94:644–651.
31. Zhou J, Zhi X, Wang L, Wang W, Li Z, Tang J,
et al. Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway. J Exp Clin Cancer Res 2015;34:135.
32. Shen X, Zhong J, Yu P, Zhao Q, Huang T. YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein. Biochem Biophys Res Commun 2019;509:448–454.
33. Wu J, Shuang Z, Zhao J, Tang H, Liu P, Zhang L,
et al. Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer. Biomed Pharmacother 2018;97:1275–1281.
34. Yu T, Xu Z, Zhang X, Men L, Nie H. Long intergenic non‑protein coding RNA 152 promotes multiple myeloma progression by negatively regulating microRNA‑497. Oncol Rep 2018;40:3763–3771.
35. Zhang PP, Wang YQ, Weng WW, Nie W, Wu Y, Deng Y,
et al. Linc00152 promotes cancer cell proliferation and invasion and predicts poor prognosis in lung adenocarcinoma. J Cancer 2017;8:2042–2050.
36. Yang Y, Sun X, Chi C, Liu Y, Lin C, Xie D,
et al. Upregulation of long noncoding RNA LINC00152 promotes proliferation and metastasis of esophageal squamous cell carcinoma. Cancer Manag Res 2019;11:4643–4654.